Ledston Equine Clinic in West Yorkshire has announced the launch of the Ledston Education Centre, which will provide training for veterinary surgeons, fire and rescue personnel, and horse owners.
The Ledston Education Centre will continue the clinic's "Tuesday evening lecture" series, and training for fire and rescue personnel will be carried out under the Safer Horse Rescues Initiative.
WebLeC is a new development through which the Centre says it will deliver online training for equine veterinary surgeons and students, and high quality equine healthcare information to horse owners across the UK. WebLeC uses web conferencing software to deliver live, interactive lectures and discussion forums to people in the comfort of their own homes.
Forthcoming WebLeC CPD meetings:
Wed 9th March 2011 at 7.30pm: "Strangles and the practical management of infectious disease outbreaks in horses"Prof. Josh Slater, BVM&S PhD DipECEIM MRCVS Professor of Clinical Equine Studies, Royal Veterinary College.Kindly sponsored by Intervet Schering-PloughFee: This meeting is FREE of charge for first 100 applicants
Thu 17th March 2011 at 7.30pm: "Insulin Resistance, Equine Metabolic Syndrome, & Equine Cushings (PPID) - a practical approach to diagnosis and management"Dr. Cathy McGowan, BVSc DipVetClinStud MACVSc PhD DEIM DipECEIM FHEA MRCVS Director of Equine Professional Studies, University of LiverpoolKindly sponsored by Boehringer IngelheimFee: This meeting is FREE of charge for first 100 applicants
Further information can be found at: http://www.ledstonequine.co.uk/weblec_lectures.html. The Ledston Education Centre says details of how to register will be available on the website shortly.
Fort Dodge Animal Health has announced that its Zulvac 8 Ovis® Bluetongue sheep vaccine is now licensed and available in the UK. The company believes that the product will provide significant benefits to sheep farmers.
Zulvac 8 Ovis® is an inactivated adjuvanted vaccine for the active immunisation of sheep by subcutaneous injection against Bluetongue Serotype 8. It also provides a reduction in viraemia. Administration is a two x 2 ml dose primary course in year one but only a single shot booster in the second year.
The use of Zulvac 8 Ovis as a booster for animals previously vaccinated with a primary course from other manufacturers is in line with Defra (2009) guidance: 'No problems are anticipated with re-vaccinating animals which have already received a primary course of vaccination with a different vaccine 1'.
The first dose can be administered from one month of age and Zulvac 8 Ovis® is proven for use in pregnant sheep. The onset of immunity is provided 25 days after the second dose.
Fort Dodge says Zulvac provides cost savings to farmers through its pricing strategy. While the price for the two dose primary course is competitive with alternative vaccines, for animals which were vaccinated last year and require only a single shot booster, the cost will be half that of competitive offerings, providing a significant incentive to farmers to vaccinate.
The vaccine is supported by a specific Zulvac Ovis fixed 2ml dose applicator with Sterimatic needle protector and cleaning system which aids administration and hygiene and is sold separately.
David Bartram MRCVS, Veterinary Technical Manager at Fort Dodge, said: "Sheep farmers have been waiting for a Bluetongue vaccine which offers a cost effective solution to vaccination - particularly for animals which received their primary course last year and are simply in need of a booster. We expect the fact that it's licensed for use in pregnant sheep to also prove attractive.
"Zulvac 8 Ovis® is the latest addition to Fort Dodge's Zulvac range for both cows and sheep. It is already used in Europe and has helped protect millions of animals."
Elanco Animal Health has announced the launch of Osurnia, a new treatment which it says will drive compliance when treating canine otitis externa infections.
According to the company, compliance with daily ear drops has been shown to be poor, with up to 80% of owners administering the incorrect dose to their pet. The most common reason for a lack of compliance is the difficultly in applying the drops1.
Elanco says that Osurnia has the potential to improve compliance in treating otitis externa significantly, because unlike other medications which require 5-28 doses during the course of treatment2, Osurnia only needs two-doses given a week apart.
Osurnia contains a gel formulation of three active ingredients including the antibiotic florfenicol, which is new to companion animal treatment in the UK, terbinafine, which inhibits the growth of yeast as demonstrated for Malassezia spp., and the glucocorticosteroid, betamethasone acetate, to help relieve discomfort.
Osurnia is administered in a pre-measured, single-dose tube designed to ensure the right dose every time. It has a flexible, soft tip designed to make treatment with Osurnia a comfortable experience for the dog. The gel formulation squeezes out of the tube and spreads through the ear, adhering inside the ear canal for long-lasting action. The dose is the same for any dog, regardless of size and weight.
Alice Laurens, DVM MRCVS, dermatology marketing manager at Elanco Animal Health said: “Otitis externa is a common challenge for both vets and clients, with ear infections among the ten most frequent reasons for dogs to be presented with vets, affecting up to 20% of dogs3.
“Osurnia is an innovative, effective treatment that is administered in just two doses ensuring it is much more convenient for pet owners thereby increasing the likelihood that they will complete the entire treatment schedule leading to more comfortable dogs and peace of mind for owners.”
Elanco has produced a client leaflet on treating otitis externa with Osurnia. For further information, or to order client leaflets, please contact your local Elanco Animal Health Territory Manager or email elancoCAH.uk@elanco.com.
References
Richard Malik from the Centre for Veterinary Education at the University of Sydney and Mike Lappin from Colorado State University, known for their amusing and questioning presentations, will be joined by experts including Jayne Sykes, Séverine Tasker, Donato Traversa and Francesca Mancianti to present the latest information about the diagnosis and treatment of a veritable smorgasbord of feline infectious diseases, including heartworm, leishmaniasis, toxocara, aspergillus, bartonella, coronavirus, erlichia, anaplasma, rickettsia, lungworm, mycobacteria, FeLV, FIV, haemoplasmas, cryptococcosis, GI disease and emerging feline pathogens.
Together with a mini-symposia organised by the congress sponsors – Idexx, Hill’s, Ceva, Bayer and Boehringer Ingelheim – the five-day event is worth 25 hours of feline CPD.
If you need more in-depth knowledge of feline infectious diseases, there are also three masterclasses planned.
The venue looks drop-dead gorgeous too. Set on a small wooded peninsula embraced by two harbours, Cavtat has a pretty waterfront peppered with restaurants, pebbly beaches and an interesting assortment of artsy attractions, making it one of the most desirable tourist destinations in the region. ISFM says it's a great base from which to explore Dubrovnik and the surrounding area.
The welcome party will take place at the congress hotel’s waterfront restaurant on Thursday evening.
Tickets cost £475 for ISFM members and £605 for non-members. Masterclasses are an additional £50 each.
That seems like an absolute steal to me, and I'm not even a vet. Where do I sign?
Ah, here it is: https://icatcare.org/isfm-congress
CEVA Animal Health has launched the anti-inflammatory Meloxidyl for cattle and pigs.
Meloxidyl is meloxicam-based solution for the management of respiratory disease, mastitis and diarrhoea in cattle and non-infectious locomotor disorders and puerperal septicaemia and toxaemia in pigs. It is given via a single injection, when used in combination with suitable anti-infectives.
According to the company, Meloxidyl's one shot protocol means it is quick and economical to use; it allows control of inflammation and endotoxins and reduces somatic cell count, recovery time and risk of culling after clinical mastitis; it reduces the economical impact of respiratory signs in comparison with flunixin-based products and reduces the major clinical signs caused by toxins in cases of neonatal diarrhoea.
Meloxidyl can be used in combination with the company's range of anti-infectives, which includes Marbokem, Cevaxel and Florkem.
For further product information contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at http://www.ceva.uk.com/
The case came after the NHS issued new guidelines for Clinical Commissioning Groups (CCG) in November 2017 which listed homeopathy alongside herbal medicine and glucosamine/chondroitin as treatments which should not now be prescribed to new patients and which CCGs should assist in de-prescribing in all patients, on the grounds that they are "products of low clinical effectiveness, where there is a lack of robust evidence of clinical effectiveness or there are significant safety concerns."
The British Homeopathic Association challenged the decision on the grounds that the public consultation which preceded the guidelines was, amongst other things, conducted unfairly and biased/predetermined.
The judge, however, ruled otherwise, saying in his ruling that the consultation was "fair and balanced" and there was "no evidence of bias or predetermination on NHSE's part".
NHS chief Simon Stevens welcomed the decision, saying: "There is no robust evidence to support homeopathy which is at best a placebo and a misuse of scarce NHS funds.
"So we strongly welcome the High Court’s clear cut decision to kick out this costly and spurious legal challenge."
Photo: Multicolored homeopathy tubes isolated on a white background. Lush. Shutterstock.
Their study, which was published in the research journal PeerJ at the end of last year1, investigated the effects of insulin on equine hoof lamellar cells in the laboratory.
The researchers say that high levels of insulin have been known for some time to cause acute endocrine laminitis, seen when ponies and certain types of horses graze lush pasture or consume a starch- or sugar-rich diet, or when they develop Cushing’s syndrome.
Many ponies and horses at risk of the condition produce large spikes of insulin in their blood stream after consuming meals high in non-structural carbohydrates (in particular starch and simple sugars) which indicates that this could be the way in which they succumb to acute endocrine laminitis.
The mechanism by which insulin can cause effects in the foot leading to laminitis has been the subject of much debate in recent years.
Hormones like insulin must interact with a specific receptor on the surface of cells in order to produce their effects. What has confused researchers in the past is that there appear to be no insulin receptors on the hoof lamellar cells (these cells give the lamellar tissues their strength and changes to their growth or structure weaken the bonds and cause laminitis).
The researchers considered the close similarities between insulin and a growth factor hormone called insulin-like growth factor -1 (IGF-1). There are receptors for IGF-1 on the lamellar cells, and the researchers speculated that high concentrations of insulin might be able to cross-stimulate these cells by activating the IGF-1 receptors. To investigate this possibility PhD student Courtnay Baskerville, together with her supervisor Professor Simon Bailey, developed a method for culturing lamellar epithelial cells in the laboratory, and incubated them with increasing concentrations of insulin.
They found that high concentrations of insulin stimulated the cells to proliferate. Furthermore, this effect could be prevented using an antibody that specifically blocks only the IGF-1 receptor. Further downstream effects within the cells were also shown. The changes seemed to occur mainly at very high concentrations of insulin. Similar concentration levels can be seen in ponies and horses with insulin dysregulation linked to Equine Metabolic Syndrome, but are not commonly seen in normal horses that are considered to be at lower risk of laminitis.
Further work is now ongoing to determine exactly how these cellular changes induced by sustained high insulin concentrations might cause laminitis. However, it seems that targeting the IGF-1 receptor may be an option for developing new drugs to prevent and treat laminitis.
Professor Simon Bailey said: "The information gathered in this study provides the equine industry worldwide with valuable insights into the causes of the common and serious condition of laminitis. The research group would like to acknowledge the support of the Waltham Centre for Pet Nutrition, in particular the involvement of Professor Pat Harris.”
Reference
Petplan has announced that it has won a formal tender to become the chosen pet insurance provider for Vets4Pets and Companion Care, as part of a five year deal to provide cover for over 250 practices.
Simon Masding, Petplan's Head of Sales and Partnerships said: "As the leader in the pet insurance market for over 36 years, we have a rich history of working with veterinary practices across the UK and it is fantastic to see our unrivalled support recognised as part of a formal tender process. This partnership demonstrates our passion for working with and supporting the veterinary profession.
"We are delighted to be Vets4Pets and Companion Care's chosen pet insurance provider and look forward to working together to help give even more pets access to quality insurance cover and an excellent claims experience."
Companion Care Commercial Director Andrei Balta said: "Like Petplan, we put pet welfare and owner's peace of mind first. Through the development of the tender process, it was clear that Petplan offers not only a world class service for pet owners, but our businesses share similar values and a deep respect for the industry."
Agrimin has announced the launch of a new range of boluses for sheep and cattle that use 'eroding technology' to deliver a sustained supply of three trace elements for up to 180 days:
According to Agrimin, each bolus is designed to provide the full daily requirement of cobalt and selenium and the largest available daily supply of iodine to both cattle and sheep. The boluses do not contain any copper, an element known to cause issues in certain parts of the country, in closely managed dairy cows or in continental sheep breeds.
Each bolus is made up of two parts, held together by a soluble wrapper. After administration, the wrapper dissolves and the two halves remain in the reticulum where they erode and dissolve. This process delivers a continuous and regular supply of nutrients to the animal.
Agrimin's Dr Jamie Bennison said that the new range has been extensively trialled in New Zealand and at Glasgow Veterinary School: "Trials have confirmed a sustained release profile which ensures that iodine, selenium and cobalt levels are maintained throughout the active life of the bolus. In farm trials this has translated into higher levels of the elements in blood samples and improved animal productivity."
Treatment is one bolus per animal (48g for sheep; 160g for cattle) administered with an Agrimin bolus gun. One bolus is sufficient to meet the animal's full daily requirement for 180 days.
For more information about the 24•7 Iodine•Selenium•Cobalt range of cattle and sheep boluses, please visit http://www.agrimin.com/ or call 01652 688046.
Petplan has announced that nominations for its 2015 Veterinary Awards will open on 1st September 2014.
The awards, which are designed to recognise members of the veterinary profession who have gone 'above and beyond' in their daily roles, will be presented on 9th April 2015.
Petplan's Acting Head of Marketing, Ingrid Wakefield said: "At Petplan, we hear from our customers every day about the exceptional care veterinary staff have given to their pets. The Veterinary Awards provide an opportunity for Petplan to show their support for members of the veterinary profession who go beyond the call of duty in their role, and for pet owners across the UK to say thank you to the veterinary staff who have helped them and their pets."
Last year Petplan received more than 12,000 nominations, with every nominee receiving a certificate of recognition for their hard work.
Nominations can be made at www.petplan.co.uk/vetawards, from the start of September.
The new site, which is ten minutes up the road from Southfield's current location in Basildon, Essex, is due to be ready in time for them to move in at the start of 2022.
When it opens, the centre will continue to offer 15 specialist-led services, but the team is projected to double in size as more specialists, clinicians and staff are recruited over the course of this year
The new premises has been made possible thanks to a big investment by parent company Linnaeus, backed by Mars Veterinary Health.
Southfields managing director Tim Richardson said: "The new hospital is a real statement of intent, a clear signal we are committed to delivering a level of excellence in treatment and care second to none.
"It will provide the region with one of the largest and best-equipped veterinary centres in, not only the UK, but also throughout Europe, with an extensive range of expertise in a wide variety of disciplines all under one roof.
"The fabulous facilities include a cutting-edge imaging suite, comprehensive treatment facilities and a new linear accelerator to assist our illustrious oncology team, which has already seen its status as one of the most experienced in the industry enhanced by the arrival of James Elliott, a renowned specialist in oncology.
"There will be seven operating theatres, 16 consultation rooms, recovery suites, lecture halls, a dedicated ICU department and there are plans for a future hydrotherapy suite.
Southfields says it also aims to lead the industry in terms of staff wellbeing, with yoga and boxercise classes among the activities available to the Southfields team.
Daniel Hogan, Southfields’ hospital director, said: “This is a huge move for us in every way. The increased size of the hospital will enable us to provide a dedicated staff wellbeing area and to offer a range of activities which will benefit our team in both body and mind.
“Along with exercise and relaxation classes, we will have an education centre which will offer some really exciting qualifications and courses for the wider profession.”
Bart Johnson, chief executive of Linnaeus, said: "This move is a reflection of the ambition of Southfields, Linnaeus and Mars to continue providing the best veterinary care in the UK."
For more information about Southfields’ new site, visit https://southfields.co.uk/veterinary-professionals/new-hospital/.
The briefing highlighted to members of both Houses the vital role the veterinary profession plays in order to ensure that the veterinary resource in clinical practice, public health, government services, academia and research is appropriately considered and effectively used during Brexit negotiations.
Lord Gardiner of Kimble, Parliamentary Under Secretary of State for the Department of Environment, Food and Rural Affairs (Defra), environment spokespeople for the Scottish National Party (SNP) and Plaid Cymru, and other parliamentarians from the Conservatives, Labour, Liberal Democrats, Plaid Cymru and the SNP, joined Crossbenchers, senior civil servants and key stakeholders at the event.
BVA President Gudrun Ravetz delivered a speech highlighting the main asks from the association's Brexit and the veterinary profession report, which was developed through consultation with BVA members, devolved branches, BVA specialist divisions and other key stakeholders.
The report sets out 52 recommendations for the short, medium and long term across seven areas of public policy: veterinary workforce, animal health, animal welfare, food hygiene and safety, veterinary medicines, research and development, and trade.
Addressing attendees, Gudrun said: "We are a relatively small profession, but we are a diverse profession with far-reaching influence and impact in so many areas of political and public life.
"Last week, we were delighted to hear the Defra Secretary of State, speaking to the Today programme, rightly acknowledged the importance of EU vets to the UK economy; from food hygiene and safety, to monitoring disease outbreaks and facilitating trade. This is why BVA is calling on the Government to guarantee the working rights for non-UK EU vets and vet nurses currently working and studying in the UK at the existing level and with no time limit.
"As we progress with the Repeal Bill we are also calling on the Government to ensure we maintain animal health and welfare current standards – and prioritise them in all trade negotiations, so that high standards of animal health, welfare and food hygiene are a unique selling point for the UK. We can only make a success of Brexit if we harness our veterinary resource."
In his speech, RCVS Junior Vice-President Professor Stephen May highlighted the three RCVS Brexit Principles as well as the findings from the College’s recent survey of non-UK EU vets working in the UK. Professor May also made a call for greater certainty from the Government on the status of EU citizens living and working as veterinary surgeons in the UK and for a substantial transition period to prevent potential veterinary workforce shortages, particularly in areas such as public health and food safety.
Professor May said: "Negotiations with our European partners will no doubt be lengthy and complex on all manner of issues that affect the veterinary sector. For everyone concerned, we join other voices in calling for a substantial transition period to any new order created. This will provide us with time to take stock, to understand the implications and to navigate a pathway that safeguards the interests of our sector and the RCVS is determined to work with all its stakeholders, in particular Government and yourselves [parliamentarians], to ensure that vital veterinary work gets done.
"Key to this will be meeting the need for high-quality, capable veterinary surgeons in all sectors. This can only be achieved in the short-term by emphasising the continued welcome and appreciation of all veterinary non-UK nationals working hard for this country, to encourage them to stay, and continued access to graduates of accredited schools from around the world, alongside increased training of UK nationals to meet our ever expanding veterinary needs."
The event was hosted by BVA Honorary Member and RCVS Past-President, Lord Trees MRCVS, who has sat on a number of House of Lords committees and subcommittees that consider and seek to influence the Government’s plans and policy-making during the UK’s exit from the EU.
Lord Trees closed the BVA and RCVS Brexit briefing by encouraging fellow Peers and MPs to capitalise on the evidence-based, science-led perspective that the veterinary profession is able to provide, particularly as Brexit discussions continue to develop.
Lord Gardiner has since publicly recognised the vital role of the veterinary profession, responding to a question in the House of Lords regarding the retention of skilled workers post-Brexit. In his role as Defra Parliamentary Under Secretary of State, Lord Gardiner said:
"I am most grateful to the noble Lord [Teverson] because I was at the BVA and RCVS reception yesterday, where I know a number of noble Lords were also in attendance. This is an important issue and an element of the negotiations that we want to deal with as promptly as possible. Yes, we do rely on and warmly welcome the support we have from EU national vets, who are hugely important to us."
It is not the first time Roundhouse Referrals has innovated in this area. Last year, it launched the first 'Fixed Price TPLO' - a guarantee that pet owners will have no additional costs, should complications arise and further treatment be required following surgery.
Ross Allan, RCVS Advanced Practitioner in Small Animal Surgery and Surgical Lead at Roundhouse Referrals, said: "We loved the idea of providing price certainty for referral clients, allowing those with no or lower levels of insurance to access our services and plan their finances. We also realised that in putting 'Fixed Price Fix' first and foremost we are also immediately highlight the possibility of complications and we felt the very best way to provide context for owners and referring vets would be to be open about our outcomes."
Following on from this Roundhouse Referrals has published the first of what it says will be a series of reports on TPLO+ clinical outcomes and customer satisfaction.
Ross said: "I think we're the first in Scotland to publish this kind of information outside scientific journals in a way that is easily accessible for pet owners, maybe in the whole of the UK."
The clinical outcome data was collected using a previously published questionnaire which enabled clients to give feedback on their pet’s recovery and status following their TPLO+ surgery.
According to Roundhouse, the results show that over 97% of dog owners rated their pets’ outcome as either excellent (85.29%) or good (11.76%) based on the first 70 TPLO+ surgeries performed. A figure which Ross says compares favourably with studies that have been previously published.
Additionally, 94.1% of pet owners agreed that if faced with having to make a similar decision again, they would choose to have the TPLO+ surgery done at Roundhouse Referrals, compared to 84.6% of owners in the previous study.
The results from the Customer Satisfaction Questionnaire showed that 100% of Roundhouse Referrals’ clients felt supported throughout the referral process, 96.97% of clients felt that the TPLO+ surgery was adequately explained and 100% would recommend Roundhouse Referrals to a friend or colleague.
Ross said: "Pet owners whose dogs’ had been through TPLO+ surgery and rehabilitation completed this questionnaire, enabling us to start measuring the outcome of the surgery, our aim being to ensure the surgery is optimal for the pet, and that owners feel supported throughout the entire surgical journey.
"We are delighted with these results, and will continue to monitor our outcomes and commit to publish our TPLO+ clinical outcome and customer satisfaction questionnaire results in the months and years ahead".
The project, which is funded by the RCVS Mind Matters Initiative, is designed to find out about current attitudes, beliefs, and alcohol use behaviours of those working in clinical settings within the UK veterinary sector.
Researchers Dr Jennifer Seddon, Olivia Cormier MRCVS, and Dr Emma Davies, from Oxford Brookes University are inviting people aged 18 and over who are working in the UK veterinary sector, including vets, veterinary nurses, practice managers, veterinary care assistants, receptionists, and those undertaking other in-practice roles, who currently drink or have drunk alcohol in the past three months to take part in an online survey which takes no more than 15 minutes.
Olivia said: “Evidence from research conducted in 2009 showed that veterinary professionals may be more likely to drink at risky levels compared to people in the general population.
"There is a vital need for new research in this area, not only so we can better understand what the current situation looks like, but so that we can learn how best to provide tailored support to this group.”
The survey is anonymous and confidential, and no personal data will be gathered or shared with MMI or the RCVS.
After completing the survey, participants can choose to enter a prize draw to win one of three £100 Amazon vouchers.
https://brookeshls.co1.qualtrics.com/jfe/form/SV_0pHn8qy4ZIVTTgy
Photo: www.depositphotos.com
The researchers say the effectiveness of cheaper devices could result in wider use amongst farmers, vets and hoof trimmers helping to identify lameness earlier.
The study, led by RVC undergraduate veterinary student, Aidan Coe, alongside Dr Nicola Blackie, a senior lecturer in Production Animal Science at the RVC, compared the thermal images of 83 cows’ hind feet, captured with both high and low cost thermal imaging devices.
Very little difference was identified in the performance and quality of the devices despite the low-cost device being 2% the cost of the high cost device.
Images captured suggested that low-cost thermal imaging devices would be the most cost-effective choice to aid in the identification of lameness.
This study highlights the effectiveness of cheaper infrared thermal imaging devices in identifying the condition which has the potential to lead to the wider use of the devices by farmers, vets and hoof trimmers, in turn allowing the condition to be identified earlier.
Whilst high-cost devices have sometimes been used to detect lameness in cattle, the price point of up to £20,000 and fragility has previously limited their usefulness in a farm setting.
Aidan Coe, Undergraduate Veterinary Student at the RVC, and lead researcher on this paper, said: “There is a possibility that low-cost infrared thermal imaging devices could be used as an objective, cost-effective method of assessing the lameness of the national herd, which may prove a useful adjunct to the current lameness detection methods.”
The full paper can be accessed at: https://www.mdpi.com/2306-7381/9/8/414
The BSAVA has announced that comic Michael McIntyre has joined the line up for Congress Party Night.
McIntyre will be joining comedian Fred MacAulay and ventriloquist Paul Zerdin
To register for BSAVA, click here.
A short survey, which has been emailed to BVA members this week, asks respondents to confirm which Official Controls Qualifications (OCQ(V)s) they currently hold or previously held.
They are also asked to give reasons if they have chosen to drop a particular qualification without revalidating it.
The BVA says members have raised concerns via Council about the OV training and revalidation process, citing time, cost, a lack of relevance and duplication of learning across different modules as reasons for choosing not to renew their qualifications.
The BVA plans to take the data and insights captured in the survey to the Animal and Plant Health Agency (APHA) and make recommendations for how the system can be made more user-friendly and fit for purpose.
John Fishwick, BVA President, said: "Official Veterinarians have a critical role to play in upholding high standards of health and welfare across the supply chain, certifying products for export and safeguarding against disease and food fraud. We are already aware that this area is facing significant challenges as Brexit is likely to drive up demand for product certification.
"It is particularly worrying to hear that members are finding the system both frustrating and resource-intensive. Losing skilled professionals now at a time when they are needed most would be a real waste of specialist knowledge and could leave gaps in the UK’s provision for responding to disease outbreaks and meeting export certification needs post-Brexit.
"We understand and support the need to keep veterinary skills up to date, but the process for demonstrating this must be straightforward and proportionate. BVA will ensure that all insights offered by respondents are raised with APHA with the aim of getting the system right for OVs working in the UK both now and in the future."
BVA members can access the survey at https://www.surveymonkey.co.uk/r/7Y2Y3RR. The deadline for responding is 29 June 2018.
The speakers include Aldo Vezzoni, a European Specialist in Small Animal Surgery, Peter Southerden, a European and RCVS Specialist in Veterinary Dentistry, orthopaedic specialist Daniel Lewis, veterinary physiotherapist Barbara Houlding, neurosurgeon Fred Wininger, Gary England, Professor of Comparative Veterinary Reproduction at Nottingham University, Rob Lowe, the ophthalmologist, Nick Bacon, Specialist in Small Animal Surgery, and Rachel Lumbis, a lecturer in Veterinary Nursing at the Royal Veterinary College, and, of course, Noel Fitzpatrick himself.
Dermatology, dentistry, ophthalmology, endoscopy and hepatobiliary disease have all been added to this year's education streams, together with a new ‘Top Tips’ stream, offering practical advice for immediate use in clinical practice.
In total, Vet Festival will have 18 separate education streams covering small animal clinical topics with dedicated nursing and rehabilitation content a key component of the programme.
The integration of veterinary professionals is a fundamental theme of the festival so, in the rehabilitation stream, surgeons, physiotherapists, rehabilitation specialists and hydrotherapists will offer perspectives in tandem.
Over the weekend, 135 lectures will be offered to suit those at every level of clinical practice. Delegates will collect 14 hours of CPD over the two days.
Also new in 2020 is the introduction of a ‘Wellness and development for you and your practice’ theatre, with speakers from both within and outside the profession, including paralympic champion Rachel Morris MBE, psychotherapist Di Gammage and mindfulness leadership specialist, Natalie Pennicotte-Collier. Various wellbeing activities, such as yoga, movement, fitness and mindfulness, will take place alongside the lectures.
Professor Noel Fitzpatrick, Clinical Chair at Fitzpatrick Referrals, who launched Vet Festival in 2015, said: "Outdoor festivals bring joy to the soul and I have always wanted education and continuing professional development to feel uplifting, inclusive and life-enhancing, both professionally and from a personal wellness perspective. That’s what VetFest is all about – food for the mind, body and soul."
Nicole Cooper, VET Festival Event Director, added: “For veterinary professionals keen to learn about the latest thinking and developments in small animal veterinary medicine, Vet Festival is simply unmissable. The breadth of content on offer and the quality of our speakers increases every year but what really sets VET Festival apart is the opportunity it offers for delegates to learn in a relaxed, fun environment.
Tickets for VET Festival can be purchased here: https://www.vetfestival.co.uk/delegate-info/ticket-information
VetSurgeon members Ian and Gillian Mostyn, and the team at Pennine Vets are doing the Coniston Challenge later this year: 30kms of arduous cycling, hiking and canoeing for Guide Dogs.
You can support them with a donation, however small (£2 minimum) at: http://www.justgiving.com/penninevetschallenge.
Invicta Animal Health has launched SynVet-50, a licensed synthetic Sodium Hyaluronate (HA), for intra-articular treatment of lameness caused by joint dysfunction associated with non-infectious synovitis in horses.
The product is Invicta's first licensed medicine.
According to the company, the functional mechanisms of HA are directly dependent on the molecular weight and concentration of HA. 1 Therefore, SynVet-50 has been formulated with a molecular weight of 1.5m Daltons which is the highest of any synthetic HA available in the UK.
Invicta says that at 20mg per ml, SynVet-50 is also the most concentrated HA available.
Storage is at ambient temperature.
SynVet-50 is a 2.5ml solution containing 50mg HA, conveniently presented in a 5ml glass syringe.
Rob Watkins, Managing Director of Invicta said: "We are excited to be launching our first licensed medicine in the UK. The management team of Invicta have over 10 years experience in this market which has allowed us to provide a product strongly focussed on the clinicians needs, not just in terms of technical ability, but also in convenience of presentation".
For further information see www.invictavet.com or phone 01403 791313
The book is described as giving comprehensive information to support the diagnosis and treatment of commonly seen pathologies of dogs and cats, such as haematology, immunology, diagnostic imaging, respiratory diseases, cardiovascular medicine, reproductive system disorders, gastrointestinal disorders, as well as hepatobiliary and exocrine pancreas disorders.
Each chapter has been authored by an internationally recognised expert in their field.
Improve says its books support delegates studying for its Postgraduate Certificate, but are also a useful reference source for other veterinary surgeons.
John Douglass, General Manager of Improve International, said: "Following the positive response to our first textbook, the Improve International Manual of Small Animal Surgery, we felt it was important to follow up with a small animal medicine equivalent. We’re therefore very happy to unveil volume one of the Improve International Manual of Clinical Small Animal Internal Medicine and look forward to the launch of the second volume later this year."
He added: "Our textbooks focus on the practical application of current veterinary knowledge, offering top tips and key advice throughout expressed in an engaging and highly visual format to ensure that they are perfect for those in need of a quick ‘look up’ in practice.”
The new books can be bought from www.improveinternational.com/uk/books, www.5mbooks.com or from booksellers worldwide. They are also available in Spanish with translations into additional languages planned.
The company says the two main benefits of the liquid formulation are precise dosing and ease of administration.
Vetmedin oral solution comes with a kg-bodyweight calibrated syringe to make it easy to give the preferred dose of 0.25 mg/kg twice daily to the nearest 0.5 kg bodyweight.
The maximum syringe volume is for a 12 kg dog.
The solution has a sweet taste to make it palatable and Boehringer says it is also ideal for dogs that need dental work but require treatment for their heart disease before general anaesthesia.
These dogs might struggle to eat chewable tablets due to oral discomfort, so a liquid treatment might be a better option.
The company highlights the EPIC1 and PROTECT2 studies which showed that Vetmedin delays the onset of CHF for dogs in the asymptomatic stage of heart disease and improves both the quality and length of life for dogs with MVD and DCM.
Vetmedin oral solution comes as a 50 ml bottle (each bottle lasts a 5 kg dog approximately 30 days), doesn't need to be refrigerated, has an 8-week shelf life once opened, and a 2-year shelf life as packaged.
VetMedin oral solution is now available to order from wholesalers.
Bob was a member of RCVS Council from 1992 until 2004 and was President in 1999/2000. During his time on Council he also served as a member of all of the major committees of that time, with the exception of the Disciplinary Committee, and chaired several of the subject boards for the RCVS Diplomas.
Current RCVS President Chris Tufnell said: "Bob was 100% responsible for my involvement with the RCVS, putting me forward for a working party in my first year in practice. Throughout his career he nurtured young professionals who he genuinely saw as the future and he was particularly dedicated to furthering and improving the education and development of veterinary surgeons, as demonstrated by his involvement in the RCVS Diplomas, the College’s continuing professional development (CPD) board and the former RCVS Trust.
"His dedication to our profession was exceptional and his kind and erudite observations, both public and private, were always welcome. We will miss him and our thoughts are with his family at this difficult time."
Photo courtesy Dulwich College.
The small animal and business meeting takes place on the 2nd and 3rd October. The farm and business national meeting is on the 18th and 19th September, and the equine and business meeting is on the 9th and 10th October.
The small animal meeting will also cover other topics such as the art of conversations to dentistry, while the farm meeting will focus on team working, competitive advantage, genomics and mental resilience.
All three events include a team-based activity and a social evening which offers the chance to network and exchange experiences and ideas.
Susan Goodfellow, the Chief Marketing Officer at XLVets said: "It's fine to know what we do but to actually experience it as part of our community is quite different. We know that talking to members and being part of a group of individuals that come together to determine their own future is the best way for veterinary professionals to see what's possible and how we strive for excellence together."
XLVets is also encouraging anyone who is thinking about starting their own practice to attend the events; the company has a number of programmes designed to support prospective owners with things like finding funding, identifying the right financial set up, and acquiring the skills needed to lead a team effectively.
Susan says many vets have a strong entrepreneurial mindset but lack support or know-how to allow them to take the first step to ownership: "Locum roles and mobile set ups are often stepping stones to practice ownership but the barriers can seem significant, not to mention any personal reservations people might have about all it entails. Support from like-minded colleagues who can openly share their experiences can help to make it seem possible, desirable and achievable."
Veterinary professionals wishing to attend one of the meetings should contact Colm McGinn, Chief of Implementation, in confidence, at colm.mcginn@xlvets.co.uk or call 01228 711788.
Virbac Animal Health has announced that registrations on BackHome BioTec, the company's microchip identification service, were moved to the Petlog Database with effect from Monday 12 September 2011.
Virbac says it moved to the UK's largest independent microchip registration database in order to offer an enhanced level of service and support, both to veterinary staff and pet owners.
Practices using the BackHome BioTec system are being asked to log onto www.virbacbackhome.co.uk to create a new account.
Gillian Brown, Product Manager for BackHome at Virbac, said: "BackHome has established itself as a popular, cost-effective and easy to use microchipping system. We believe that in appointing Petlog to manage our registrations we will now be offering a 'best of breed' service for veterinary staff and pet owners.
"We're extremely grateful to Celia Walsom, Petlog Executive, and her team. They have demonstrated unfailing energy, expertise and total dedication to ensuring this move has run smoothly and effectively for all our customers. I am confident that they will benefit from Petlog's commitment to provide a comprehensive identification service which is easy, convenient and secure to use.
"All our existing customers need to do is go to the new website (www.virbacbackhome.co.uk/) and set up an account - it's a simple and quick process. We'll also be providing a range of promotional materials to help them communicate the change to their own clients."
Petlog is owned and managed by the Kennel Club. Virbac says it is fully data compliant and defers income to ensure it can honour its lifetime promise to pet owners. Its Lost and Found helpline is available 24/7, 365 days a year and it is also a founder member of the European Pet Network.
Further information on BackHome BioTec is available on the new website, which also contains a direct link to Petlog.
For further information about BackHome BioTec, please contact your Virbac Territory Manager or call the company on 01359 243243.